ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
European Commission approves PONVORY™ --- A Once Daily Oral Treatment for Adults with Relapsing Forms of Multiple Sclerosis
May 25, 2021Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced that the European Commission (EC) has approved PONVORY™ (ponesimod) for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease defined by ... -
Novartis Announces New Ofatumumab Data at EAN
June 03, 2020Novartis announced new ofatumumab data from the Phase III ASCLEPIOS trials and the Phase II APLIOS trial were presented virtually at the 6th Congress of the European Academy of Neurology (EAN).
Pharma Sources Insight January 2025
